Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05586204 · ClinicalTrials.gov registry record · NA
Boost Intentions and Facilitate Action to Promote COVID-19 Booster Take-up
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 154,977
- Enrollment target
NCT05586204 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 154,977 participants.
The verdict
NCT05586204, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 154,977 participants
- Enrollment target
Study Summary
This is a prospective randomized clinical trial evaluating how behaviorally-informed outreach text messages affect the take-up of bivalent COVID-19 booster. The investigators will test the impact of sending text reminders as well as the importance of elevating vaccination intentions, facilitating action, and their combination.
Interventions
- BEHAVIORAL Eligibility reminder
- BEHAVIORAL Link to a narrow set of vaccine venues
- BEHAVIORAL Link to a broad set of vaccine venues
- BEHAVIORAL Doctors' recommendation and value of vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154,977 participants |
| Start Date | 2022-10-18 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05586204
The ClinicalTrials.gov registry entry for NCT05586204 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154,977 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Eligibility reminder is the first listed.
NCT05586204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05586204 about?
NCT05586204 is a clinical study titled "Boost Intentions and Facilitate Action to Promote COVID-19 Booster Take-up". This is a prospective randomized clinical trial evaluating how behaviorally-informed outreach text messages affect the take-up of bivalent COVID-19 booster. The investigators will test the impact of sending text reminders as well as the importance of elevating vaccination intentions, facilitating ac...
What is the current status of trial NCT05586204?
This trial is currently completed. It is a NA study. The enrollment target is 154,977 participants. The study started on 2022-10-18. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05586204?
The interventions under investigation include: Eligibility reminder (BEHAVIORAL), Link to a narrow set of vaccine venues (BEHAVIORAL), Link to a broad set of vaccine venues (BEHAVIORAL), Doctors' recommendation and value of vaccine (BEHAVIORAL).
Who is sponsoring clinical trial NCT05586204?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.